OSE Immunotherapeutics SA (EPA:OSE)
5.82
+0.21 (3.74%)
Apr 1, 2025, 3:43 PM CET
OSE Immunotherapeutics Revenue
In the year 2024, OSE Immunotherapeutics had annual revenue of 83.44M EUR with 3,646.52% growth. OSE Immunotherapeutics had revenue of 862.00K in the half year ending December 31, 2024, a decrease of -61.77%.
Revenue
83.44M
Revenue Growth
+3,646.52%
P/S Ratio
1.47
Revenue / Employee
1.60M
Employees
55
Market Cap
122.71M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 83.44M | 81.21M | 3,646.52% |
Dec 31, 2023 | 2.23M | -16.08M | -87.83% |
Dec 31, 2022 | 18.30M | -8.00M | -30.43% |
Dec 31, 2021 | 26.31M | 15.89M | 152.48% |
Dec 31, 2020 | 10.42M | -15.53M | -59.85% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 44.29B |
EssilorLuxottica Société anonyme | 26.51B |
Sartorius Stedim Biotech | 2.78B |
bioMérieux | 3.98B |
Eurofins Scientific SE | 6.95B |
Ipsen | 3.57B |
Virbac | 1.40B |
emeis Société anonyme | 5.43B |